FGF18 induces chondrogenesis and anti-osteoarthritic effects in a mouse model for TMJ degeneration
PLOS One · 2025
DOI: 10.1371/journal.pone.0317816 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Flavia Gomes Velasque Gama und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthodontics, UConn Health, Farmington, Connecticut, United States of America. Hauptthemen laut MEDLINE: Osteoarthritis, Chondrogenesis, Fibroblast Growth Factors, Temporomandibular Joint Disorders. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NIDCR NIH HHS, American Association of Orthodontists Foundation, Foundation for the National Institutes of Health.
Abstract (Originalsprache)
Objective
Temporomandibular Joint Osteoarthritis (TMJ-OA) is a degenerative disease characterized by progressive loss of cartilage and subchondral bone sclerosis. Currently there are no effective treatments for TMJ-OA. FGF18 is a member of the fibroblast growth factor family with essential roles for chondrogenesis, selectively binding to FGFR3 receptor. Studies have reported FGF18 attenuates cartilage degradation. Whereas the anti-osteoarthritic effects of FGF18 in the articular cartilage are known, the effects of FGF18 in a TMJ fibrocartilage degeneration mouse model remain to be determined. The goal of this project was to determine the effects of intra-articular injections of FGF18 in a mouse model for TMJ degeneration.
Method
Prosthesis tubes were bonded at the left lower incisor of 6-week-old triple collagen transgenic mice (Col1a1XCol2a1XCol10a1), creating unilateral crossbite and degeneration of the TMJ fibrocartilage. Six weeks after placement of prosthesis tubes, experimental and control mice received intra-articular injections of rmFGF18 (5µg/week) or saline, respectively, for 3 weeks.
Results
Mice receiving saline intra-articular injections presented with a thinner cartilage layer with decreased proteoglycan distribution and Edu positive cells (chondrocyte proliferation marker), while mice injected with rmFGF18 presented with significant increased fibrocartilage thickness, remarkable proteoglycan distribution and chondrocyte proliferation, suggesting healing of the induced degeneration. Furthermore, reversal of the TMJ degeneration achieved by rmFGF18 injection was accompanied by a substantial reduction in Noggin (antagonist of BMP signaling), increase in TIMP1 (inhibitor of metalloproteinases such as MMP13) and decrease in MMP13 expression.
Conclusion
Our results postulate FGF18 as a powerful growth factor for the healing of TMJ fibrocartilage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Orthodontics, UConn Health, Farmington, Connecticut, United States of America.
ORCID-Profile: Eliane Hermes Dutra
Förderung
- NIDCR NIH HHS
- American Association of Orthodontists Foundation
- Foundation for the National Institutes of Health
Zitieren
APA
Gomes Velasque Gama, F., Casciani, C., & Dutra, E. H. (2025). FGF18 induces chondrogenesis and anti-osteoarthritic effects in a mouse model for TMJ degeneration. PLOS One. https://doi.org/10.1371/journal.pone.0317816
Vancouver
Gomes Velasque Gama F, Casciani C, Dutra EH. FGF18 induces chondrogenesis and anti-osteoarthritic effects in a mouse model for TMJ degeneration. PLOS One. 2025. doi:10.1371/journal.pone.0317816
BibTeX
@article{GomesVelasqueGama2025,
author = {Gomes Velasque Gama, Flavia and Casciani, Christina and Dutra, Eliane Hermes},
title = {FGF18 induces chondrogenesis and anti-osteoarthritic effects in a mouse model for TMJ degeneration},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0317816}
}
EUVIMED